A risk model for severe anemia to select cancer patients for primary prophylaxis with epoetin alpha: a prospective randomized controlled trial of the ELYPSE study group.

Ray-Coquard, I; Dussart, S; Goillot, C; Mayeur, D; Debourdeau, P; Ghesquieres, H; Bachelot, T; Le Cesne, A; Anglaret, B; Agostini, C; Guastalla, J-P; Lancry, L; Biron, P; Desseigne, F; Blay, J-Y

Ray-Coquard, I; Dussart, S; Goillot, C; Mayeur, D; Debourdeau, P; Ghesquieres, H; Bachelot, T; Le Cesne, A; Anglaret, B; Agostini, C; Guastalla, J-P; Lancry, L; Biron, P; Desseigne, F; Blay, J-Y.

Affiliation

Ray-Coquard I; Department of Medical Oncology, Léon Bérard Comprehensive Cancer Center, University of Lyon, and EA 4128 SIS Individu Santé, Société, Lyon, France. ray@lyon.fnclcc.fr

Ann Oncol ; 20(6): 1105-12, 2009 Jun.

Article in En | MEDLINE | ID: mdl-19174452

Subject(s)

Anemia/drug therapy; Erythropoietin/administration & dosage; Hematinics/administration & dosage; Neoplasms/complications; Adult; Aged; Aged, 80 and over; Anemia/etiology; Chemoprevention; Epoetin Alfa; Female; Humans; Male; Middle Aged; Models, Biological; Prospective Studies; Recombinant Proteins; Risk Factors

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Erythropoietin / Hematinics / Anemia / Neoplasms Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2009 Document type: Article Affiliation country: France Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google